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INTRODUCTION
Transmissible gastroenteritis (TGE) is a highly infectious viral disease of pigs, causing a high mortality rate in young piglets. Minor strain differences between TGE viruses have been shown by neutralization tests with polyclonal antibodies (Harada et al., 1967; Kemeny, 1976) . Monoclonal (MC) antibodies have proved an extremely useful addition to the field of immunology (KShler and Milstein, 1975; Blann, 1979 ) : since they react with only one antigenic determinant (epitope) they are ideal reagents for studying antigenic structure and variation.
In the present study, MC antibodies were raised to TGE virus, strain , and used to examine antigenic variation of the virus.
MATERIALS AND METHODS

Cell cultures
The CPK cell line derived from swine kidney ( Komaniwa et al., 1981 ) was grown in Eagle's minimum essential medium (MEM) containing 10% calf serum, 10% tryptose phosphate broth (TPB) (Difco, U.S.A. ), 100 units ml-1 penicillin and 100/~g ml-1 streptomycin. The maintenance medium was MEM containing 10% TPB, 0.11% bovine serum albumin and antibiotics as above. Primary swine kidney cells dispersed by trypsin were grown and maintained in the same culture media as used for CPK cells.
Viruses
The TGE virus strains used were TO-163 (Harada et al., 1967; Furuuchi et al., 1975) , h-5, Kanagawa (Harada et al., 1967) , Purdue (Laude et al., 1981 ) , Ukiha, Shizuoka (Harada et al., 1967) and Miller (Bohl and Cross, 1971 ). The T0-163, Kanagawa, Purdue, Shizuoka and Miller strains were provided by the National Institute of Animal Health of Japan. The h-5 and Ukiha strains were obtained from commercially available vaccines and had been maintained by serial passage in primary swine kidney cell cultures. After two or three passages in these cultures in our laboratory, the strains were stored at -80 ° C. Infectivity assay was carried out in microplate cultures of CPK cells by the method described previously (Yamagishi et al., 1981 ) . The titer was expressed in 50% tissue culture infectious dose (TCID5o).
Preparation of antiserum against T0-163 strain
The antiserum was prepared in specific pathogen-free pigs, 2 months of age. The animals received two intramuscular doses of 108 TCID5o each at intervals of 2 months. Serum was obtained 10 days after the second inoculation.
Preparation of virus antigen
The antigen was prepared with the T0-163 strain grown in CPK cell cultures. Infectious culture fluid concentrated about 10-fold by ammonium sulfate precipitation was layered onto a discontinuous sucrose density gradient (20-60%) in a SW 28 rotor (Beckman) and centrifuged at 27 000 r.p.m, for 2 h. The virus bands formed were collected, mixed with an equal volume of fluorocarbon (Wako Pure Chemicals, Japan) and vigorously shaken for 2 min. 117 The water phase was separated by centrifugation and layered onto a linear sucrose density gradient (20-60%) in a SW 28 rotor and centrifuged at 27 000 r.p.m, for 4 h. Fractions with densities of 1.18-1.20 g m1-1 were pooled and centrifuged at 77 000Xg for 1 h. The pellets were resuspended in a 1/500 volume of NTE buffer (0.1 M NaCl, 0.01 M Tris-HC1, pH 7.4, 0.001 M EDTA). The suspension was treated with 1% Triton X-100 for 1 h at 4 °C and dialyzed against phosphate buffered saline (PBS) (0.1 M NaCl, 0.01 M phosphate buffer, pH 7.2 ). The resulting material was used for mouse immunization and enzyme-linked immunosorbent assay (see below).
Production of antibody-secreting hybrydomas
BALB/c mice, about 5 weeks of age, were inoculated intraperitoneally with a mixture of 10 pg of the viral antigen prepared as above and 109 cells of pertussis adjuvant. Four or 6 weeks later the mice received an intravenous booster dose of 10 pg of viral antigen, and spleen cells were obtained for fusion 3 days later. The fusion was carried out using essentially the same method as that described by KShler and Milstein (1975) . Polyethyleneglycol-1000 ( Wako Pure Chemicals, Japan) was used as a fusing agent and the ratio of mouse spleen cells and mouse myeloma cells (SP2/O) was 10:1. The selective medium contained hypoxanthine (10 -4 M), aminopterin (4×10 -7 M) and thymidine (1.6 X 10-~ M). The fused cells at a concentration ef 3.5 X 106 spleen cells per ml were dispensed in 100 ttl volumes into wells of 96-well, flat-bottomed microplates (Corning Glass Works, Corning, NY) and incubated at 37 ° C in a humid atmosphere containing 5% C02. After incubation for 2 weeks, the wells were examined and those which contained hybridoma cultures were tested for TGE specific antibody by an enzyme-linked immunosorbent assay ( see below ). The colonies in antibody positive wells were passaged in 24-well multiplates ( Corning Glass Works, Corning, NY) and incubated in medium containing hypoxanthine (10-4 M ) and thymidine (1.6 X 10-~ M ). The cells were then cloned twice by the soft agar method.
Production of MC antibodies in ascitic fluids
BALB/c mice were injected intraperitoneally with 0.5 ml of pristane (2,6,10,14-tetramethylpentadecane) { Aldrich, U.S.A.) 14 days before intraperitoneal inoculation of 2 X 106 hybridoma cells. Ten days later the ascitic fluids were collected, clarified by centrifugation and stored at -80 ° C until use.
Determination of antibody class and subclass
The supernatant fluids of antibody-secreting hybridoma cultures were concentrated 10-fold by 50% saturation of ammonium sulfate and used for deter-mination of antibody class and subclass by double diffusion in a 1% agar gel containing 0.1% NAN3. Rabbit antisera against mouse immunoglobulins, IgG1, IgG2a, IgG2b, IgG3, IgM and IgA, and kappa and lambda chains (Miles Laboratories, U.S.A. ) were placed in the center wells and test samples were added to adjacent wells. The plates were incubated overnight at room temperature in a humidified chamber.
Enzyme-linked immunosorbent assay ( ELISA )
Virus antigen (see above) was appropriately diluted with carbonate buffer (0.05 M, pH 9.6) and delivered in 100 #l volumes into wells of 96-well, flatbottomed Microelisa plates ( Dynatech. Lab., U.S.A. ). The plates were allowed to stand overnight at 4 ° C, washed with 0.85% NaCl solution containing 0.02% Tween-20, and 100 pl of the test sample was added to each well. Horseradish peroxidase-conjugated rabbit antibodies against mouse immunoglobulins were diluted to the optimal concentration with PBS containing 10% calf serum and 0.05% Tween-20 and 100 pl of the dilution was added to each well of the plates. After incubation at 37°C for 30 min, each well received 100 pl of substrate solution and incubated at 25 ° C for 20 min in a dark room. The substrate solution was prepared by dissolving O-phenylenediamine dihydrochloride at a concentration of 0.4 mg m1-1 in 0.1 M citric acid-0.2 M Na2HP04 buffer (pH 4.8) and adding 0.2 ~l ml-1 of 30% H202. After completion of the incubation, the reaction was stopped with 3 N H2SO4 solution and the optical density (OD) at 492 nm was determined.
Neutralization (NT) test
NT tests were carried out by the antibody dilution method in CPK cell cultures prepared in flat-bottomed microplates (Corning Glass Works, Corning, NY ). 25/A of each of serial 2-fold dilutions of the antibody inactivated at 56 ° C for 30 min were mixed with 25 }tl of maintenance medium containing 200 TCIDso of virus in wells of a transfer plate. Four wells were employed for each antibody dilution. The virus-antibody mixtures were incubated at 37°C for 60 min, transferred into wells of a microplate containing CPK cell cultures, and incubated in an atmosphere of 5% CO2 in air at 37 °C for 5 days. The antibody titer was expressed as the reciprocal of the antibody dilution showing 50% NT calculated by the method of K~irber.
Peroxidase-labeled MC antibody
This was prepared by the method of Nakane and Kawaoi (1974) . MC antibodies from ascitic fluid were purified by 3 cycles of precipitation with (NH4) 2SO4 at 35 % saturation. Ten mg of the purified MC antibody was mixed 119 with 4 mg of horseradish peroxidase oxidized with 0.1 M NaIO4 in 0.01 M carbonate buffer (pH 9.6) at room temperature for 2 h. After addition of 4 mg NaBH4 solution and incubation at 4 °C for 2 h, the mixture was dialyzed against 0.01 M PBS (pH 7.2). The enzyme conjugated antibody was separated from the enzyme and unconjugated antibody on a Sephadex G-200 column.
Competitive binding assay
This was carried out by a modified ELISA (Kimura-Kuroda and Yasui, 1983 ) . One hundred zl of serial 10-fold dilutions of each competing MC antibody from ascitic fluid were added to wells of a flat-bottomed Microelisa plate coated with virus antigen ( see above ), and incubated at 37 ° C for 60 min. After three washings with 0.85% NaC1 solution containing 0.02% Tween-20, 100 #l of peroxidase-labeled MC antibody (see above) diluted to an OD of 1.0 was added. The competitive binding was estimated from the ODs in the presence or absence of unlabeled competing antibodies. The percentage of competition was determined by the formula: 100 (A -n) / (A -B ) , where A is the OD in the absence of competing antibody, B is the OD in the presence of homologous antibody (10 t ELISA units), and n is the OD in the presence of competitor.
RESULTS
Isolation and characterization of MC antibodies
In two fusion experiments, hybridoma cultures were obtained in 152 of 632 inoculated wells. Antibody-positive colonies were cloned twice in soft agar, and 21 clones secreting MC antibody were finally obtained. Of these cloned cells, 14, six and one produced IgG1, IgG2a, and IgM antibodies, respectively. All of these MC antibodies had light chains of the kappa type (Table I ) .
Reactivity of MC antibodies to the T0-163 strain
The reactivity of the MC antibodies to the TO-163 strain of TGE virus was examined by NT and ELISA using the mouse ascitic fluid and the culture fluid concentration 10-fold by 50% saturation of ammonium sulfate. As shown in Table I , eight of the 21 MC antibodies had NT activity. Of these, three antibodies (4-4, 75-4, 66-A) had high antibody titers in both the NT and ELISA tests, and four (55-2, 16-C, 38-A, 39-7) had high ELISA titers, but low NT titers, 10-fold to 100-fold lower than those of 4-4, 75-4 and 66-A MC antibodies, and one (9-C) had rather low ELISA and NT titers. The remaining 13 MC antibodies showed positive ELISA titers but no NT activity. Culture fluid of mouse myeloma cells (SP2/O) concentrated 10-fold by ammonium sulfate was negative in ELISA and NT. 
Variation in NT activity of MC antibodies to TGE virus strains
Seven strains of TGE virus were examined for their antigenicity by NT tests using the eight MC antibodies with NT activity to the TO-163 strain. The results are summarized in Table II . Based on these results the seven virus strains could be classified into four groups: the TO-163, h-5 and Kanagawa strains in Group I, the Purdue strain in Group II, the Ukiha strain in Group III, and the Shizuoka and Miller strains in Group IV.
MC antibodies 4-4, 55-2 and 38-A, demonstrated NT activity to all of the virus strains tested, although the 38-A antibody showed low titers compared with those of 4-4 and 55-2. The 16-C antibody neutralized the six virus strain in Groups I, III and IV, but not the Purdue strain of Group II, while the 9-C antibody neutralized all the strains except the Ukiha strain in Group III. The 66-A and 75-4 antibodies showed high NT activities to the strains of Group I, but low NT activity to the Purdue strain of Group II, and no NT activity to the strains of Group III and Group IV. The 39-7 antibody exhibited NT activity only to the Group I strains, but none to the other four strains in Groups II, III and IV. The polyclonal antiserum to the TO-163 strain prepared in a pig showed essentially the same NT titers to all the virus strains and could not differentiate between them. The TO-163 and Shizuoka strains at low and high passage levels in swine kidney cell cultures were tested against the eight MC antibodies with NT activity against the TO-163 strains. As shown in Table III , the low-passage TO strain showed an NT titer pattern quite different from that of the high-passage TO strain. The high-passage TO strain (176 passages) showed the NT titer pattern of Group I, whereas the low-passage TO strain (17 passages) demonstrated an NT titer pattern similar to that of Group IV (Tables II and III) . On the other hand, the Shizuoka strain showed no difference in NT titer pattern between the low-passage ( 22 passages) and high-passage virus (163 passages), the NT titer pattern being that of Group IV (Tables II and III) . Table IV summarizes the results of the competitive binding assay. Enzymelabeled 4-4 and 55-2 MC antibodies were blocked completely by either one of these antibodies, and similar results were obtained with MC antibodies, 66-A and 75-4. MC antibodies 38-A, 16-C, 9-C and 39-7 completely blocked only homologous enzyme-labeled antibody. MC antibodies 66-A and 75-4, partially blocked enzyme-labeled antibodies 4-4, 55-2, 38-A, 16-C, 9-C and 39-7.
Results of competitive binding assay
DISCUSSION
Three major structural proteins have been demonstrated in the virion of TGE virus. They include phosphorylated nucleocapsid protein (N), glycosylated envelope protein { E1 ) and glycosylated peplomer protein (E2) (Jacobs et al., 1986; Laude et al., 1986 ) . Garwes et al. (1979) reported that glycoprotein VP1 (E2) was the structural component of virus surface projections and that a preparation of virus surface projections produced NT antibody in animals. Laude et al. (1986) raised MC antibodies against structural proteins of TGE virus and showed all major NT-mediating determinants to be carried by E2 peplomer protein. The epitopes recognized by our panel of MC antibodies with NT activity may also be present on E2 peplomer protein. MC antibodies reacting in ELISA but having no NT activity may recognize epitopes on N or E1 proteins. Further studies are required to elucidate the epitopes for these MC antibodies by Western immunoblotting, immunoprecipitation and other methods.
Comparison of seven TGE strains by NT tests using our panel of MC antibodies confirmed their close antigenic relationships, but also revealed the occurrence of distinct antigenic differences (Table II) . Similar results were reported by Laude et al. (1986) . The results of NT tests on the seven TGE strains (Table II) suggest that there may be at least six NT-mediating determinants on the virion of the TO-163 strain. These six epitopes are as follows:
(1) the epitope recognized by MC antibodies, 4-4 and 55-2, which showed high NT activity for all the virus strains; (2) the epitope recognized by MC antibody, 38-A, which showed low NT activity for all the virus strains; (3) the epitope recognized by MC antibody 16-C, which showed NT activity for all the virus strains except the Purdue strain: (4) the epitope recognized by MC antibody 9-C, which showed NT activity for all the virus strains except the Ukiha strain; (5) the epitope recognized by MC antibodies, 66-A and 75-4, which showed high NT activity for the TO-163, h-5 and Kanagawa strains, very low NT activity for the Purdue strain and no NT activity for the Ukiha, Shizuoka and Miller strains; (6) the epitope recognized by MC antibody 39-7, which showed NT activity for the TO-163, h-5 and Kanagawa strains, but no NT activity for the other four virus strains.
The presence of six epitopes was confirmed by the competitive binding assay (Table IV) : MC antibodies 4-4 and 55-2 recognized one epitope and 66-A and 75-4 recognized another, while antibodies 38-A, 16-C, 9-C and 39-7 each recognized one distinct epitope. These results are in good agreement with those of NT tests (Table II) . MC antibodies 66-A and 75-4 blocked enzyme-labeled antibodies 4-4, 55-2, 38-A, 16-C, 9-C and 39-7 to some extent but the reason for this is obscure.
As shown in Table II , the seven TGE strains were similarly neutralized with polyclonal antibodies against the TO-163 strain. This finding suggests that subunit vaccines containing E2 protein of the TO-163 strain may have protective efficacy against other strains. MC antibodies 4-4 and 55-2 may be useful for purification of E2 protein.
